Syndax Pharmaceuticals Inc. logo

Syndax Pharmaceuticals Inc. (SNDX)

Market Closed
20 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
22. 29
-0.51
-2.2368%
After Hours
$
23. 10
+0.81 +3.6339%
2.09B Market Cap
- P/E Ratio
- Div Yield
1.31M Volume
-2.96 Eps
$ 22.8
Previous Close
Add Transaction
Day Range
22.28 23.27
Year Range
9.38 25.59
Want to track SNDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Syndax Pharmaceuticals Inc. (SNDX) Statistics

Valuation metrics

Market Cap 2.09B
Enterprise value 2.23B
Trailing P/E (ttm) -8.14
Forward P/E -90.26
PEG ratio -0.24
Price/Sales (ttm) 9.3
Price/Book (mrq) 47.45
Enterprise Value/Revenue 10.29
Enterprise Value/EBITDA -13.75

Overview

Shares outstanding 88.54M
Float 75.1M
Shares short 19.91M
% Held by insiders 0.02%
% Held by institutions 1.16%
Average volume (10 days) 1.97M
Average volume (90 days) 1.8M

Price summary

52-Week low 9.38
52-Week high 25.59
Beta 0.41
50-Day moving average 21.61
200-Day moving average 21.77

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -1.12%
Operating margin -1.03%

Operational effectiveness

Return on assets -0.51%
Return on equity -2.57%

Income Statement

Revenue (ttm) 217.17M
Revenue per share (ttm) 2.51
Quarterly revenue growth (yoy) 2.24%
Gross profit (ttm) -50.33M
EBITDA -224.17M
Net income to common (ttm) -243.25M
Diluted EPS (ttm) -2.81
Quarterly earnings growth (yoy) 2.24%

Balance Sheet

Total cash (mrq) 361.24M
Total cash per share (mrq) 4.06
Total debt (mrq) 345.36M
Total Debt/Equity (mrq) 8.3
Current ratio (mrq) 5.47%
Book value per share (mrq) 0.48

Cash Flow

Cash flow statement -278.16M
Levered free cash flow (LFCF) -186.26M